Cargando…

Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study

INTRODUCTION: Observational studies using case-control designs have showed an increased risk of pneumonia associated with inhaled corticosteroid (ICS)-containing medications in patients with chronic obstructive pulmonary disease (COPD). New-user observational cohort designs may minimize biases assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	DiSantostefano, Rachael L., Sampson, Tim, Le, Hoa Van, Hinds, David, Davis, Kourtney J., Bakerly, Nawar Diar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039434/ https://www.ncbi.nlm.nih.gov/pubmed/24878543 http://dx.doi.org/10.1371/journal.pone.0097149

Ejemplares similares

Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis
por: Hinds, David R, et al.
Publicado: (2016)

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013)

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2014)

The role of inhaled and/or nasal corticosteroids on the bronchodilator response
por: Lee, Ju Kyung, et al.
Publicado: (2010)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
por: Bishwakarma, Raju, et al.
Publicado: (2017)

Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)
por: Quint, Jennifer K, et al.
Publicado: (2014)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
por: Asche, Carl Victor, et al.
Publicado: (2012)

Correction to: Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis
por: El Baou, Céline, et al.
Publicado: (2017)

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD
por: Jara, Michele, et al.
Publicado: (2012)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

Prescribing Patterns for Long-Acting Inhaled Bronchodilators Among Rural Adults With Chronic Obstructive Pulmonary Disease
por: Brunner, Wendy M., et al.
Publicado: (2022)

Annotating and detecting phenotypic information for chronic obstructive pulmonary disease
por: Ju, Meizhi, et al.
Publicado: (2019)

Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study
por: Wurst, Keele E, et al.
Publicado: (2014)

Obtaining real-world evidence: the Salford Lung Study
por: New, John P, et al.
Publicado: (2014)

Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study feasibility
por: Elkhenini, Hanaa F, et al.
Publicado: (2015)

Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population
por: Tsai, Ming-Jun, et al.
Publicado: (2015)

Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease
por: Wang, Meng-Ting, et al.
Publicado: (2019)

The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease
por: Bakerly, Nawar Diar, et al.
Publicado: (2021)

The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease
por: Bakerly, Nawar Diar, et al.
Publicado: (2015)

Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions
por: Clouse, Brian J., et al.
Publicado: (2016)

Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources
por: Alhaider, S.A., et al.
Publicado: (2014)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
por: Cazzola, Mario, et al.
Publicado: (2019)

Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population: Erratum
Publicado: (2016)

A study of attitudes, beliefs and organisational barriers related to safe emergency oxygen therapy for patients with COPD (chronic obstructive pulmonary disease) in clinical practice and research
por: O'Driscoll, B Ronan, et al.
Publicado: (2016)

Using Societal Values to Inform Public Health Policy During the COVID-19 Pandemic: The Role of Health Preference Research
por: DiSantostefano, Rachael L., et al.
Publicado: (2021)

Pembrolizumab-associated bronchiolitis in an elderly lung cancer patient required the treatment with an inhaled corticosteroid, erythromycin and bronchodilators
por: Yamaya, Takafumi, et al.
Publicado: (2019)

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
por: Miravitlles, Marc, et al.
Publicado: (2022)

Cardiovascular morbidity and the use of inhaled bronchodilators
por: Macie, Christine, et al.
Publicado: (2008)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
por: Calverley, Peter M, et al.
Publicado: (2016)

Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
por: Halpin, David M. G., et al.
Publicado: (2016)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β(2)-Agonist–Inhaled Corticosteroid Rescue
por: Lugogo, Njira, et al.
Publicado: (2023)

Advancing Digital Solutions to Overcome Longstanding Barriers in Asthma and COPD Management
por: Bosnic-Anticevich, Sinthia, et al.
Publicado: (2023)

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L, et al.
Publicado: (2014)

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
por: Donohue, James F, et al.
Publicado: (2011)

Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans
por: Calabrese, Cecilia, et al.
Publicado: (2016)

Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study
por: Kozma, Chris M, et al.
Publicado: (2011)

The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease
por: Souliotis, Kyriakos, et al.
Publicado: (2020)

The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease
por: Shin, Hong-Joon, et al.
Publicado: (2021)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h8ktn41ak479rgm9kphrpqi5cv